| Literature DB >> 35116050 |
Cristina Sáez1, Alejandro Flores-León1, Javier Montero-Pau2, Alicia Sifres1, Narinder P S Dhillon3, Carmelo López1, Belén Picó1.
Abstract
Tomato leaf curl New Delhi virus (ToLCNDV) emerged in the Mediterranean Basin in 2012 as the first DNA bipartite begomovirus (Geminiviridae family), causing severe yield and economic losses in cucurbit crops. A major resistance locus was identified in the wild melon accession WM-7 (Cucumis melo kachri group), but the mechanisms involved in the resistant response remained unknown. In this work, we used RNA-sequencing to identify disease-associated genes that are differentially expressed in the course of ToLCNDV infection and could contribute to resistance. Transcriptomes of the resistant WM-7 genotype and the susceptible cultivar Piñonet Piel de Sapo (PS) (C. melo ibericus group) in ToLCNDV and mock inoculated plants were compared at four time points during infection (0, 3, 6, and 12 days post inoculation). Different gene expression patterns were observed over time in the resistant and susceptible genotypes in comparison to their respective controls. Differentially expressed genes (DEGs) in ToLCNDV-infected plants were classified using gene ontology (GO) terms, and genes of the categories transcription, DNA replication, and helicase activity were downregulated in WM-7 but upregulated in PS, suggesting that reduced activity of these functions reduces ToLCNDV replication and intercellular spread and thereby contributes to resistance. DEGs involved in the jasmonic acid signaling pathway, photosynthesis, RNA silencing, transmembrane, and sugar transporters entail adverse consequences for systemic infection in the resistant genotype, and lead to susceptibility in PS. The expression levels of selected candidate genes were validated by qRT-PCR to corroborate their differential expression upon ToLCNDV infection in resistant and susceptible melon. Furthermore, single nucleotide polymorphism (SNPs) with an effect on structural functionality of DEGs linked to the main QTLs for ToLCNDV resistance have been identified. The obtained results pinpoint cellular functions and candidate genes that are differentially expressed in a resistant and susceptible melon line in response to ToLCNDV, an information of great relevance for breeding ToLCNDV-resistant melon cultivars.Entities:
Keywords: DEG (differentially expressed genes); ToLCNDV resistance; melon (Cucumis melo L.); qPCR (quantitative polymerase chain reaction); transcriptome (RNA-seq)
Year: 2022 PMID: 35116050 PMCID: PMC8805612 DOI: 10.3389/fpls.2021.798858
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Summary of the RNA-Seq experimental design, read alignment, and differentially expressed genes (DEGs).
| Sample name | Inoculation treatment | Time point dpi | Replicate | Cleaned reads | Mapped reads | % Mapped reads | DEGs |
| WM-7_0dpi_1 | Uninoculated | 0 | 1 | 96,571,093 | 92,933,140 | 96.23 | – |
| WM-7_0dpi_2 | 0 | 2 | 89,738,162 | 86,520,235 | 96.41 | ||
| WM-7_I3dpi_1 | ToLCNDV inoculated | 3 | 1 | 96,017,670 | 92,139,780 | 95.96 | 292 |
| WM-7_I3dpi_2 | 3 | 2 | 90,412,987 | 87,094,110 | 96.33 | ||
| WM-7_B3dpi_1 | Mock inoculated | 3 | 1 | 97,337,221 | 93,893,779 | 96.46 | |
| WM-7_B3dpi_2 | 3 | 2 | 90,083,950 | 53,101,818 | 58.95 | ||
| WM-7_I6dpi_1 | ToLCNDV inoculated | 6 | 1 | 95,502,062 | 88,222,091 | 92.38 | 354 |
| WM-7_I6dpi_2 | 6 | 2 | 89,625,183 | 74,603,092 | 83.24 | ||
| WM-7_B6dpi_1 | Mock inoculated | 6 | 1 | 96,044,324 | 92,625,513 | 96.44 | |
| WM-7_B6dpi_2 | 6 | 2 | 90,375,930 | 86,463,397 | 95.67 | ||
| WM-7_I12dpi_1 | ToLCNDV inoculated | 12 | 1 | 96,637,024 | 92,925,369 | 96.16 | 558 |
| WM-7_I12dpi_2 | 12 | 2 | 90,324,017 | 86,939,559 | 96.25 | ||
| WM-7_B12dpi_1 | Mock inoculated | 12 | 1 | 97,444,807 | 94,078,242 | 96.55 | |
| WM-7_B12dpi_2 | 12 | 2 | 91,063,342 | 87,570,888 | 96.16 | ||
| PS_0dpi_1 | Uninoculated | 0 | 1 | 102,027,470 | 95,339,552 | 93.44 | – |
| PS_0dpi_2 | 0 | 2 | 90,578,076 | 87,236,559 | 96.31 | ||
| PS_I3dpi_1 | ToLCNDV inoculated | 3 | 1 | 95,503,001 | 91,778,653 | 96.1 | 404 |
| PS_I3dpi_2 | 3 | 2 | 60,411,004 | 57,587,132 | 95.33 | ||
| PS_B3dpi_1 | Mock inoculated | 3 | 1 | 97,063,008 | 93,062,108 | 95.88 | |
| PS_B3dpi_2 | 3 | 2 | 92,073,644 | 88,433,510 | 96.05 | ||
| PS_I6dpi_1 | ToLCNDV inoculated | 6 | 1 | 96,678,397 | 92,088,929 | 95.25 | 752 |
| PS_I6dpi_2 | 6 | 2 | 93,655,611 | 89,233,728 | 95.28 | ||
| PS_B6dpi_1 | Mock inoculated | 6 | 1 | 96,653,614 | 92,903,742 | 96.12 | |
| PS_B6dpi_2 | 6 | 2 | 91,746,137 | 88,232,317 | 96.17 | ||
| PS_I12dpi_1 | ToLCNDV inoculated | 12 | 1 | 95,935,797 | 92,131,302 | 96.03 | 981 |
| PS_I12dpi_2 | 12 | 2 | 91,460,724 | 87,827,401 | 96.03 | ||
| PS_B12dpi_1 | Mock inoculated | 12 | 1 | 96,368,610 | 92,693,418 | 96.19 | |
| PS_B12dpi_2 | 12 | 2 | 89,485,860 | 85,736,511 | 95.81 |
Assigned name to each sample, their temporal and inoculation treatment, and replicates performed are shown. Proportion of uniquely clean reads mapped against the reference melon genome (v4.0), and differentially expressed genes comparing firstly with 0 dpi control and then between mock and ToLCNDV inoculated treatments are provided.
FIGURE 1Assessment of WM-7 and PS response to ToLCNDV-ES infection in the first total expanded apical leaf of each plant. Temporal evolution of symptomatology (A) and mean of viral titers (B) in WM-7 and PS.
FIGURE 2Module eigengenes across samples for the gene clusters GC19 and GC20 (A). KEGG enrichment profile of up- and down-represented genes within each cluster (B). I: ToLCNDV inoculated; B: mock inoculated; 01: 0 dpi, 3: 3 dpi, 6: 6 dpi, 12: 12 dpi.
FIGURE 3Volcano plots display DEG distribution for each time point at 3, 6, and 12 dpi in both PS and WM-7. Orange dots represent the upregulated genes and blue dots downregulated genes. The x-axis correspond to log2 (fold change) and the y-axis to –log10 (p-adjusted). Black dots represent those DEGs not considered significant with p-adjusted ≥ 0.05 (green line shows the cutoff) and gray dots those DEGs differing from mock-inoculated treatments in 1.5 < log2 (fold change) > 1.5.
FIGURE 4Venn diagrams representing common and specific up and down DEGs identified in WM-7 and PS (A); common and specific DEGs at 3, 6, and 12 dpi in WM-7 (B) and PS (C).
FIGURE 5Gene ontology (GO) classification. The number of upregulated or downregulated genes assigned to each class were calculated at 3, 6, and 12 dpi to WM-7 and PS and represented in colors according with the legend.
Differentially expressed genes in the candidate region for ToLCNDV resistance of C. melo chromosome 11.
| Log2 (Fold Change) | |||||||
| Gen | Stage dpi | ToLCNDV inoculated | Mock inoculated | Start | End | Function | |
|
| MELO3C022339.2 | 6 | –3.08 | – | 30,494,799 | 30,495,239 | Glutaredoxin |
| MELO3C022300.2 | 12 | 2.179 | – | 30,156,612 | 30,160,071 | Probably inactive receptor-like protein kinase At2g46850 | |
| MELO3C022324.2 | 12 | 1.888 | – | 30,394,274 | 30,397,789 | Proton pump-interactor 2-like | |
| MELO3C022341.2 | 12 | 10.806 | – | 30,509,871 | 30,512,205 | Bidirectional sugar transporter SWEET | |
| MELO3C022358.2 | 12 | 1.451 | – | 30,691,737 | 30,692,270 | Ethylene-responsive transcription factor ERF113-like | |
| MELO3C022365.2 | 12 | 1.743 | – | 30,715,606 | 30,716,293 | UPF0481 protein | |
| MELO3C022367.2 | 12 | 1.168 | – | 30,725,006 | 30,743,460 | UPF0481 protein At3g47200 | |
|
| MELO3C022327.2 | 3 | –2.809 | – | 30,409,446 | 30,410,934 | Transmembrane protein, putative |
| MELO3C022337.2 | 3 | –1.075 | – | 30,481,662 | 30,482,590 | Auxin-responsive protein SAUR36 | |
| MELO3C022327.2 | 6 | –3.596 | – | 30,409,446 | 30,410,934 | Transmembrane protein, putative | |
| MELO3C022319.2 | 12 | –1.075 | – | 30,347,186 | 30,355,934 | DNA primase large subunit | |
Differentially expressed genes identified between the 70 R-genes of the melon genome characterized in Islam et al. (2020).
| log2 (Fold Change) | Gene | |||||||||||
| 3 dpi | 6 dpi | 12 dpi | ||||||||||
| ToLCNDV inoculated | Mock inoculated | ToLCNDV inoculated | Mock inoculated | ToLCNDV inoculated | Mock inoculated | Chromosome | Start | End | Function | Functional disease resistance-related domains | ||
|
| MELO3C023579.2 | 1.305 | – | 1.492 | – | 1 | 32,573,956 | 32,576,619 | Disease resistance protein RGA2-like isoform X1 | LRR | ||
| MELO3C023578.2 | –1.063 | – | 1 | 32,588,913 | 32,593,637 | Disease resistance protein | NB-ARC | |||||
| MELO3C023441.2 | –1.232 | – | 1 | 33,623,112 | 33,627,816 | Receptor-kinase, putative | LRR | |||||
| MELO3C010826.2 | 3.548 | – | 3 | 28,214,790 | 28,218,285 | Receptor-kinase, putative | LRR | |||||
| MELO3C010825.2 | 6.754 | 4.610 | 3 | 28,218,855 | 28,226,256 | Receptor-kinase, putative | LRR | |||||
| MELO3C009693.2 | 1.112 | – | 1.407 | – | 4 | 28,945,912 | 28,948,344 | Disease resistance protein | NB-ARC | |||
| MELO3C009179.2 | 1.429 | – | 4 | 32,531,221 | 32,534,345 | Receptor-kinase, putative | LRR | |||||
| MELO3C004289.2 | –1.145 | – | 1.062 | – | 5 | 25,863,643 | 25,869,731 | TMV resistance protein N-like | TIR-NBS-LRR | |||
| MELO3C004303.2 | 1.697 | – | 1.664 | – | 5 | 26,036,017 | 26,040,632 | TMV resistance protein N-like | LRR | |||
| MELO3C004311.2 | 1.560 | – | 2.700 | – | 5 | 26,076,967 | 26,095,083 | TMV resistance protein N-like | TIR-NBS-LRR | |||
| MELO3C004313.2 | 2.177 | – | 1.771 | – | 5 | 26,106,563 | 26,109,785 | TMV resistance protein N-like | TIR-NBS-LRR | |||
| MELO3C017703.2 | –1.062 | – | 7 | 24,126,814 | 24,129,634 | Disease resistance protein RGA2-like | NB-ARC | |||||
| MELO3C022146.2 | 2.410 | – | 9 | 744,523 | 750,028 | TMV resistance protein N-like | TIR-NBS-LRR | |||||
| MELO3C022144.2 | 1.048 | – | 1.406 | – | 9 | 767,040 | 775,410 | TMV resistance protein N-like | TIR-NBS-LRR | |||
| MELO3C005450.2 | 2.717 | – | 3.153 | – | 9 | 20,427,143 | 20,430,013 | LRR receptor-like kinase family protein | LRR | |||
| MELO3C005451.2 | 5.330 | – | 7.293 | 3.030 | 9 | 20,434,381 | 20,437,380 | LRR receptor-like kinase | LRR | |||
| MELO3C002506.2 | 1.722 | – | 3.179 | – | 12 | 22,229,817 | 22,238,994 | Receptor-like protein kinase | RLK | |||
| MELO3C002504.2 | –1.634 | – | 2.234 | – | 12 | 22,242,891 | 22,252,225 | Cysteine-rich receptor-like protein kinase 28 | RLK | |||
| MELO3C002501.2 | 2.578 | – | 12 | 22,262,412 | 22,265,400 | Cysteine-rich receptor-like protein kinase 26isoform X1 | RLK | |||||
|
| MELO3C009694.2 | 1.795 | – | 4 | 28,938,791 | 28,941,261 | Disease resistance protein | NB-ARC | ||||
| MELO3C004309.2 | 2.092 | – | 5 | 26,060,336 | 26,066,739 | TMV resistance protein N-like | TIR-NBS-LRR | |||||
| MELO3C022449.2 | –4.838 | – | 11 | 31,293,359 | 31,296,020 | Receptor-like protein | LRR | |||||
Expression pattern of each gene is presented as log2 (fold change) at 3, 6, and 12 dpi stages. Physical position of genes according to v4.0 of melon genome, functional annotation, and disease resistance–related domain are included.
TIR-NBS-LRR: Toll/interleukin-1 receptor homology nucleotide-binding site leucine-rich repeat. Function: pathogen specificity and defense.
LRR: Leucine-rich repeat. Function: Recognition of pathogen and Plant Defense.
NB-ARC: Nucleotide-binding adaptor shared by APAF-1, R proteins and CED-4. Function: molecular switch in activating defenses.
RLK: Protein kinase. Function: Signaling and plant.defense.
Expression pattern of additional selected genes conferring resistance to pathogens.
| log2 (Fold Change) | Gene | |||||||||||
| 3 dpi | 6 dpi | 12 dpi | Chr | Start | End | Function | ||||||
| ToLCNDV inoculated | Mock inoculated | ToLCNDV inoculated | Mock inoculated | ToLCNDV inoculated | Mock inoculated | |||||||
|
| MELO3C018539.2 | 6.232 | – | 1 | 1,023,454 | 1,024,330 | Pathogenesis-related protein 1-like | |||||
| MELO3C018540.2 | 4.757 | – | 1 | 1,030,810 | 1,031,348 | pathogenesis-related protein 1-like | ||||||
| MELO3C018544.2 | 1.148 | – | 1 | 1,042,545 | 1,043,212 | Pathogenesis-related protein 1 | ||||||
| MELO3C018547.2 | 2.416 | – | 1 | 1,051,651 | 1,052,250 | Pathogenesis-related protein 1 | ||||||
| MELO3C018878.2 | 3.820 | – | 1 | 3,559,447 | 3,560,191 | Pathogen-induced protein CuPi1 | ||||||
| MELO3C023694.2 | 3.590 | – | 1 | 6,394,591 | 6,396,233 | Pathogen-related protein | ||||||
| MELO3C023578.2 | –1.063 | – | 1 | 32,588,913 | 32,593,637 | Disease resistance protein | ||||||
| MELO3C017322.2 | –1.803 | – | 2 | 24,275,353 | 24,280,275 | LEAF RUST 10 DISEASE-RESISTANCE LOCUS RECEPTOR-LIKE PROTEIN KINASE-like 1.2 isoform X2 | ||||||
| MELO3C008149.2 | 1.310 | – | 2.130 | – | 3 | 1,163,259 | 1,172,229 | LEAF RUST 10 DISEASE-RESISTANCE LOCUS RECEPTOR-LIKE PROTEIN KINASE-like 1.4 isoform X1 | ||||
| MELO3C031443.2 | 1.049 | – | 5 | 18,385,406 | 18,392,554 | TMV resistance protein N | ||||||
| MELO3C004262.2 | 4.967 | – | 7.110 | – | 5 | 25,614,803 | 25,621,533 | TMV resistance protein N-like | ||||
| MELO3C004265.2 | –3.999 | – | 5 | 25,650,358 | 25,651,288 | TMV resistance protein N-like isoform X2 | ||||||
| MELO3C004291.2 | 3.994 | – | 5.272 | – | 5 | 25,906,332 | 25,908,625 | TMV resistance protein N-like | ||||
| MELO3C031332.2 | 6.714 | 4.701 | 5 | 26,375,103 | 26,376,034 | Disease resistance protein | ||||||
| MELO3C004354.2 | 1.032 | – | 1.137 | – | 5 | 26,592,987 | 26,596,766 | CC-NBS-LRR resistance protein | ||||
| MELO3C004385.2 | 5.488 | – | 5 | 26,848,627 | 26,849,611 | Pathogenesis-related protein PR-4-like | ||||||
| MELO3C019482.2 | –1.096 | – | 6 | 10,571,172 | 10,573,959 | Pathogenesis-related thaumatin-like protein | ||||||
| MELO3C016941.2 | 1.139 | – | 7 | 947,005 | 948,144 | Protein ENHANCED DISEASE RESISTANCE 2 | ||||||
| MELO3C017692.2 | 4.161 | – | 7 | 24,081,397 | 24,084,555 | Disease resistance protein RGA2-like | ||||||
| MELO3C017703.2 | –1.062 | – | 7 | 24,126,814 | 24,129,634 | Disease resistance protein RGA2-like | ||||||
| MELO3C033615.2 | 1.350 | - | 1.808 | – | 9 | 6,658,398 | 6,659,268 | Disease resistance protein RGA2-like | ||||
| MELO3C029858.2 | –1.042 | – | 9 | 20,748,481 | 20,749,427 | NBS resistance-like protein | ||||||
| MELO3C020880.2 | –1.323 | – | 11 | 3,294,068 | 3,294,968 | Pathogenesis-related protein 1 | ||||||
| MELO3C024731.2 | 3.364 | – | 11 | 7,170,632 | 7,173,642 | Disease resistance protein RGA2-like | ||||||
| MELO3C002084.2 | 2.412 | – | 2.657 | – | 12 | 24,991,237 | 24,991,695 | Protein NEGATIVE REGULATOR OF RESISTANCE | ||||
|
| MELO3C018796.2 | –2.636 | – | –6.437 | – | 1 | 2,864,020 | 2,864,927 | Cysteine-rich receptor-kinase-like protein | |||
| MELO3C018540.2 | 5.297 | – | 5.506 | – | 1 | 1,030,810 | 1,031,348 | Pathogenesis-related protein 1-like | ||||
| MELO3C018539.2 | 5.704 | – | 1 | 1,023,454 | 1,024,330 | Pathogenesis-related protein 1-like | ||||||
| MELO3C012701.2 | 1.438 | – | 1 | 21,798,030 | 21,798,830 | Cysteine proteinase inhibitor | ||||||
| MELO3C012702.2 | 1.869 | – | 1 | 21,826,195 | 21,827,118 | Cysteine proteinase inhibitor | ||||||
| MELO3C017497.2 | 5.171 | – | 2 | 22,319,516 | 22,320,537 | Pathogenesis-related protein PR-1 | ||||||
| MELO3C008149.2 | 1.128 | – | 3 | 1,163,259 | 1,172,229 | LEAF RUST 10 DISEASE-RESISTANCE LOCUS RECEPTOR-LIKE PROTEIN KINASE-like 1.4 isoform X1 | ||||||
| MELO3C031111.2 | 1.548 | – | 1.533 | – | 5 | 7,065,995 | 7,068,688 | Negative regulator of systemic acquired resistance SNI1 | ||||
| MELO3C004261.2 | 2.559 | – | 5 | 25,594,168 | 25,594,730 | TMV resistance protein N-like | ||||||
| MELO3C004309.2 | 2.056 | – | 2.092 | – | 5 | 26,060,336 | 26,066,739 | LOW QUALITY PROTEIN: TMV resistance protein N-like | ||||
| MELO3C016128.2 | –1.373 | – | 7 | 19,211,072 | 19,212,632 | Pathogen-related protein | ||||||
| MELO3C017071.2 | 1.514 | – | 7 | 123,638 | 125,187 | Cysteine/Histidine-rich C1 domain family protein | ||||||
| MELO3C022150.2 | 2.260 | – | 9 | 703,234 | 708,384 | TMV resistance protein N-like | ||||||
| MELO3C033944.2 | –3.577 | –7.025 | –4.180 | – | 9 | 16,122,393 | 16,123,197 | NBS-LRR type resistance protein | ||||
| MELO3C002921.2 | 1.250 | – | 1.610 | – | 1.477 | – | 9 | 7,641,728 | 7,642,167 | Cysteine proteinase inhibitor | ||
| MELO3C002492.2 | 4.266 | – | 3.409 | – | 12 | 22,299,334 | 22,300,624 | Cysteine-rich receptor-like protein kinase 25 | ||||
FIGURE 6Relative expression 2(−ΔΔCt) of seven candidate genes for ToLCNDV resistance determined by qRT-PCR.